Skip to main navigation Skip to search Skip to main content

A phase II study of Catrix-S in solid tumors

  • Charles F. Romano
  • , Allan Lipton
  • , Harold A. Harvey
  • , Mary A. Simmonds
  • , Paula J. Romano
  • , Sharon L. Imboden

Research output: Contribution to journalArticlepeer-review

Abstract

Catrix-S is an acidic mucopolysaccharide complex derived from bovine tracheal cartilage. This material was administered by weekly subcutaneous injection (5.0-7.5 g/week) to nine patients with progressive metastatic malignancy. One complete response was seen in a patient with metastatic renal cell carcinoma to the lungs. Eight patients had progression of their disease. No undue toxicity and no consistent immunologic alteration was noted.

Original languageEnglish (US)
Pages (from-to)585-589
Number of pages5
JournalJournal of Biological Response Modifiers
Volume4
Issue number6
StatePublished - Dec 1985

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Immunology
  • Pharmacology
  • Cancer Research

Fingerprint

Dive into the research topics of 'A phase II study of Catrix-S in solid tumors'. Together they form a unique fingerprint.

Cite this